Skip to main content
. 2021 Jan 4;186(1):79–87. doi: 10.1007/s10549-020-06037-y

Fig. 3.

Fig. 3

Breast cancer patient overall survival is associated with primary tumor NMT2 status. Kaplan–Meier overall survival analysis based on NMT2 score of 706 breast adenocarcinoma tissue samples stained with 6C5E8 NMT2 mAb. The solid line represents survival outcomes of patients with a negative NMT2 score (N = 509) while the dashed line represents survival outcomes of patients with a positive NMT2 score (N = 197). (logrank test P = 0.029)